On March 26, neurologist Dr. Sharon Cohen joins us to walk through the early signs of Alzheimer's, the conditions that can look like dementia but aren't, and how to have a productive conversation with your doctor.
Bring your questions. Register to join live: https://bit.ly/4qhsHsO
In 2025, 182 clinical trials evaluated 138 experimental drugs, reflecting real momentum in how scientists understand the biology, genetics, and biomarkers driving this disease.
Learn how that progress is translating into new ways to treat the disease.
🔴 WATCH LIVE TODAY: https://bit.ly/4aR3j7l
The image is a promotional banner for "Glaucoma Chats," featuring Inas F. Aboobakar, MD. It includes text: "Discussing Glaucoma With Your Family," scheduled for Wednesday, March 11, 1 pm Eastern.
Family history is one of the strongest risk factors for glaucoma.
Dr. Inas Aboobakar joins Glaucoma Chats to explain the role of genetics and family history in glaucoma, what and when to share with relatives, and how to encourage glaucoma eye exams.
Register: https://bit.ly/4u7l1Lh
From disease-modifying therapies and oral pills to non-pharmacological options, the Alzheimer’s treatment pipeline includes a wider range of approaches than ever before.
Read about what’s to come in 2026 and beyond: https://bit.ly/4aMpGcS.
Induced neurons derived from an Alzheimer’s Disease patient. Green: Tuj, Red: NeuN.
Check out these stunning brain cells derived from a person with Alzheimer’s disease.
• Green = Young
• Red = Mature
Dr. Josephy Herdy is using these stem cells to study how to stop brain inflammation in Alzheimer’s disease.
Explore the research: https://bit.ly/3OqvJfz
Early-stage AMD often has no symptoms. By the time people notice vision changes, the disease may have already progressed.
That's why Paul, a stand-up comedian living with AMD, recommends comprehensive eye exams for everyone over 40, even if your vision seems fine. https://bit.ly/49L8K7n.
🧬 LIVE today at 1 p.m. ET: Dr. Eric M. Reiman joins us to discuss APOE4, genetic testing, and what it means for your Alzheimer's risk. We'll also discuss treatments, potential side effects, and clinical research opportunities. Your questions welcome! ↘️
https://www.youtube.com/live/XDRd-MRpDRY
Could we prevent Alzheimer's before memory loss begins?
Dr. Joshua Grill explains how researchers are exploring early treatment to slow or stop brain changes associated with Alzheimer’s disease in people at higher risk.
Learn more about this promising area of research ➡️ https://bit.ly/4k3QPMP.
Did you know? As many as 20 million U.S. adults aged 40 and older are living with some form of AMD.
Age-related macular degeneration (AMD) is a leading cause of vision loss, yet many people don't know they have it until irreversible vision loss occurs.
This #AMDAwarenessMonth, learn about the importance of regular eye exams, symptoms, risk factors & the latest research: https://bit.ly/4tzVDO1.
Image with text on a dark blue background. The text states: "FACT: Macular degeneration is the leading cause of vision loss in Americans 65 and older, causing irreversible damage that affects reading, driving, and recognizing faces."
Reading a text message, recognizing a grandchild's face, navigating a familiar route: these ordinary acts rely on central vision. For nearly 20 million Americans, age-related macular degeneration puts all of that at risk.
But early detection offers hope. Learn more: https://bit.ly/4bD2WOG.
Breaking News: On Feb 3, Congress passed, and the President signed into law, the Fiscal Year 2026 appropriations bill providing critical federal funding for the NIH, protecting brain and eye research.
Read more. https://bit.ly/46qFBvV
You wouldn't skip your other wellness appointments—so why skip eye exams?
Cynthia reminds us that protecting our vision deserves the same priority we give to other aspects of self-care. Watch her story. ⬇️
Get the facts about glaucoma this #GlaucomaAwarenessMonth: www.stopglaucoma.org
Graphic for a Macular Chat titled: Can Retinal Implants Restore Vision?
TOMORROW: Learn how retinal prostheses are designed to restore vision—not just slow its loss. Join us Wed, Jan 28 at 1 pm ET to explore the PRIMA implant and other breakthrough technologies currently in production.
Watch live: https://bit.ly/4qJtjXX
This is an eye from a frog that was treated with CRISPR. Because CRISPR mutations that cause gene knockdown are random, we can sometimes get mosaicism, where some cells are healthy, and then the cells beside them are mutants. This is an excellent example of mosaicism, where some photoreceptors are healthy (left side), and others are mutants (right side).
CRISPR in action! The healthy cells (left) & disease-modified cells (right) create a 'mosaic' pattern, typical of gene editing.
Dr. Brittany Carr, BrightFocus Foundation Macular Degeneration Research grantee, is using this technique to build more precise disease models. https://bit.ly/3YKpMMC
For decades, Alzheimer's drugs only treated symptoms. That's changed. Two FDA-approved therapies now target amyloid protein in the brain. But what does that mean for people living with the disease?
Watch live: https://www.youtube.com/live/41AMx2fsdHM
Graphic for Zoom In on Dementia & Alzheimer's
Until recently, there were no Alzheimer's drugs that targeted the underlying causes of the disease. Now there are two.
On Jan 22, hear from a leading neurologist about Leqembi and Kisunla—how they work, who's eligible, and what you need to know.
Register: https://bit.ly/4qhsHsO
Glaucoma doesn’t just affect older adults. It can affect anyone at any age.
Hillary explains why everyone, not just individuals with known risk factors, can benefit from regular eye exams to spot the earliest signs of glaucoma and other eye diseases.
Learn more at: www.stopglaucoma.org
Join tomorrow's Glaucoma Chat with Dr. Mehul Nagarsheth, who will break down how early diagnosis opens the door to modern, less invasive treatment options.
🎧 Listen live tomorrow, Jan. 14 at 1 p.m. ET: https://bit.ly/4qFdiBH
Too many people see multiple specialists before receiving an Alzheimer’s diagnosis, losing precious time.
BrightFocus Foundation supports the Alzheimer’s Policy Working Group’s initiative to provide actionable policy guidance to accelerate diagnosis and improve care.
Read the report: alzpolicy.org
BrightFocus Foundation Alzheimer’s Disease Research grant recipient Joe Herdy, PhD
“I watched my grandfather’s sharp, witty mind fade away with dementia. That experience drives me to search for answers so other families don’t feel the same helplessness.”
— Joe Herdy, PhD, BrightFocus Foundation Alzheimer's Disease Research grant recipient.
Read more: https://bit.ly/4jAd4d1
Glaucoma treatment has come a long way. Register for our Jan. 14 Glaucoma Chat where Dr. Mehul Nagarsheth will break down how diagnosing glaucoma earlier gives you access to modern, less invasive treatments.
🔗 Register today and ask your questions live. https://bit.ly/3NyIYub
An individual holding a tennis racket smiles while playing tennis, with a promotional message 'Why Young Brains Stay Sharp With Age'
🧠 Why do some people stay sharp at 85 while others struggle at 76?
The answer is "cognitive reserve," your brain's built-in resilience that can be strengthened through lifelong learning, physical activity, social connections, and proactive health management.
Learn more: https://bit.ly/49nPMCf
whole mount merge iba1rbpms retina
The red cells are microglia—your eye's tiny defenders. 🛡️ These immune cells patrol the retina, protecting it from damage. Silvia Marinelli, PhD, a BrightFocus Foundation National Glaucoma Research grant recipient, is studying how we might harness them to fight vision loss.
🔬 https://bit.ly/4q6Ubkj
We're thrilled to announce that our Alzheimer's Fast Track 2025 workshop is being as the AARP Brain Health Action Collaborative Action of the Week!
By connecting early-career scientists with leading experts, we’re igniting new ideas to advance Alzheimer's research: https://bit.ly/3MOcThQ.
🌍 Smart science knows no borders!
BrightFocus Foundation is funding innovative research across 16 countries, supporting 186 projects that are advancing our understanding of Alzheimer's, macular degeneration, and glaucoma.
Explore our 2025 research portfolios: https://bit.ly/4sa1OrC
Graphic featuring a close-up of a researcher's hand holding a blood sample in a lab, with racks of test tubes in the background.
🧠 Researchers have identified a promising new class of blood biomarkers known as circular RNAs (circRNAs) for early Alzheimer's detection.
Read more : https://bit.ly/3N7zR3m
Fluorescence microscopy images of two cells, the left stained prominently in blue and green, and the right featuring multicolored speckles predominantly in blue, green, and red.
BrightFocus Foundation Alzheimer’s Disease Research grant recipient Dr. Hongjun Fu grows “mini-brains” to study why certain neurons are vulnerable in Alzheimer’s & PSP.
These images show brain tissue at 60 days (left) and 120 days (right).
Read more about Dr. Fu’s project: https://bit.ly/4s29wnt
The EVOKE trials found that semaglutide, the GLP-1 drug behind several popular diabetes and weight loss medications, did not meaningfully slow cognitive decline in people with Alzheimer’s disease.
Explore this research and more news from #CTAD2025. https://bit.ly/48KgAxG
Did you know some people maintain sharp thinking skills even with Alzheimer's-related brain changes?
Building cognitive reserve through lifelong learning, social connections, and healthy lifestyle choices may help protect your brain.
Learn more: https://bit.ly/3MmMgAo
New study results indicate that lifestyle changes can protect aging brains. The U.S. POINTER study tested whether a structured, healthy lifestyle program could protect cognitive function in at-risk older adults. The answer is YES.
Explore this news and more from #CTAD2025: https://bit.ly/4pTAgoa
